EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its September 2025 meeting.…

EMA’s safety committee (PRAC) has started a review of medicines containing levamisole, authorised in four…

1. A global and integrated view of safety 🌐🔍 Artificial Intelligence (AI) enables the collection…

📌 Introduction Pharmacovigilance is a key medical and scientific discipline essential to public health. Its…

At its March meeting, EMA’s Management Board elected Rui Santos Ivo as new chair of…

Adopted following the Covid-19 pandemic and established by Regulation (EU) 2021/522 of 24 March 2021,…

At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities,…